Please Wait.....
Report
Research Antibodies & Reagents Market by Product (Antibodies (Type, Form, Source, Research Area), Reagents), Technology (Western blot, Flow Cytometry, ELISA), Application (Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global forecast to 2027
Market Report I 2022-07-04 I 276 Pages I MarketsandMarkets
The research antibodies and reagents market is projected to reach USD 16.1 billion by 2027 from USD 11.6 billion in 2022, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market evolved owing to factors such as increasing proteomics and genomics research, growing demand for antibodies for research reproducibility, and increasing R&D expenditure in the life sciences industry. Driven by the increasing demand for personalized medicine and structure-based drug design. It is expected that the global research antibodies and reagentsmarket will witness significant growth in the coming years.
On the basis ofproduct, the reagentssegment holds the highest market share during the forecast period.
On the basis of product, the research antibodies and reagents market are segmented into reagent and antibodies. In 2021the reagent segment accounted for the larger market share. Factors such as increasing applications of biosciences and biotechnology within the healthcare and pharmaceutical fields is driving the market.
On the basis oftechnology, theflow cytometrysegmentis expected to register the highest CAGR during the forecast period.
On the basis of technology, the research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. During the forecast period the flow cytometry segment is expected to witness the highest growth. Factors such as advantages of this technique, its ability to perform simultaneous multi-parameter analysis on single cells within a heterogeneous mixture, offering high throughput along with technological innovations in flow cytometry and increasingoncology research, are driving the growth of this segment.
On the basis ofapplication, the proteomicsholds the highest market share during the forecast period.
On the basis of application, the research antibodies and reagents market is segmented into proteomics, drug development and Genomics. In 2021, Proteomics held the largest share of the global research antibodies and reagents market. Factors such as increasing efficiency maps drug-protein and protein-protein interactions. Additionally, proteomic technologies have minimized the cost, time, and resource requirements for chemical synthesis and biological testing of drugs and are highly efficient. Such factors are driving the market.
On the basis of enduser, the pharmaceutical & biotechnology holds the highest market share during the forecast period.
The research antibodies and reagents market is divided into the pharmaceutical & biotechnology companies, academic & research institutions and Contract Research Organizations. In 2021the pharmaceutical & biotechnology companies held the largest share of the global research antibodies and reagents end-user market. Factors such as growing use of research antibodies in drug development for the identification and quantification of biomarkers and other techniques are driving the market.
By Region, The Asia Pacific region is expected to register the highest CAGR during the forecast period.
During the forecast period (2022 to 2027), the Asia Pacific research antibodies and reagents market is expected to grow at the highest CAGR. Factors such as increasing research in proteomics and genomics and growing research funding, investments by pharmaceutical and biotechnology companies, and growing awareness in the region are driving the market in the region.
Break of primary participants was as mentioned below:
- By Company Type - Tier 1-35%, Tier 2-45% and Tier 3-20%
- By Designation - C-level-35%, Director-level-25%, Others-40%
- By Region - North America-45%, Europe-30%, AsiaPacific-20%, Latin America- 3%, Middle East and Africa-2%
Key players in the research antibodies and reagentsmarket
The key players operating in the research antibodies and reagents systems includeThermo Fisher Scientific, Inc. US), Merck KGaA (Germany), Abcam plc. (UK), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), Danaher Corporation (US), Agilent Technologies (US), PerkinElmer (US), Lonza (Switzerland), GenScript (China), and BioLegend (US).
Research Coverage:
The report analyzes the research antibodies and reagent marketand aims at estimating the market size and future growth potential of this market based on various segments such as product, distribution channel, andregion. The report also includes aproduct portfolio matrix of various research antibodies and reagents productsavailable in the market. The report also providesa competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would helpthem, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies tostrengthen their position in the market.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global research antibodies and reagentmarket. The report analyzes this marketby product and distribution channel.
- Product Enhancement/Innovation: Detailed insights on upcoming trends and productlaunches in the globalresearch antibodies and reagentmarket.
- Market Development: Comprehensive information on the lucrative emerging markets by product and distribution channel
- Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in theglobal research antibodies and reagent market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in theglobal research antibodies and reagent market.
1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.2.1 INCLUSIONS & EXCLUSIONS 34
1.2.2 MARKETS COVERED 35
FIGURE 1 GLOBAL RESEARCH ANTIBODIES AND REAGENTS MARKET 35
FIGURE 2 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SCOPE 36
1.2.3 YEARS CONSIDERED FOR THE STUDY 36
1.3 CURRENCY 37
1.4 STAKEHOLDERS 37
1.5 LIMITATIONS 37
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
FIGURE 3 RESEARCH DESIGN 38
2.1.1 SECONDARY RESEARCH 39
2.1.1.1 Key data from secondary sources 39
2.1.2 PRIMARY RESEARCH 40
FIGURE 4 PRIMARY SOURCES 40
2.1.2.1 Key data from primary sources 41
2.1.2.2 Breakdown of primaries 41
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 42
FIGURE 6 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 7 MARKET SIZING FROM COMPANY REVENUE 43
FIGURE 8 MARKET ANALYSIS APPROACH 44
FIGURE 9 TOP-DOWN APPROACH 44
2.3 DATA TRIANGULATION APPROACH 46
FIGURE 10 DATA TRIANGULATION METHODOLOGY 46
2.4 MARKET SHARE ESTIMATION 47
2.5 ASSUMPTIONS FOR THE STUDY 47
?
3 EXECUTIVE SUMMARY 48
FIGURE 11 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 48
FIGURE 12 RESEARCH ANTIBODIES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 49
FIGURE 13 RESEARCH REAGENTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 49
FIGURE 14 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 50
FIGURE 15 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 50
FIGURE 16 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 51
FIGURE 17 GEOGRAPHIC ANALYSIS: RESEARCH ANTIBODIES AND REAGENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 RESEARCH ANTIBODIES AND REAGENTS: MARKET OVERVIEW 53
FIGURE 18 INCREASING R&D EXPENDITURE IN THE LIFE SCIENCE INDUSTRY TO DRIVE MARKET GROWTH 53
4.2 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION 54
FIGURE 19 PROTEOMICS ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC RESEARCH ANTIBODIES AND REAGENTS MARKET IN 2021 54
4.3 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 20 CHINA SHOWS THE HIGHEST REVENUE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 55
4.4 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION 56
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE RESEARCH ANTIBODIES AND REAGENTS MARKET UNTIL 2027 56
4.5 RESEARCH ANTIBODIES AND REAGENTS MARKET: DEVELOPED VS. DEVELOPING MARKETS 56
FIGURE 22 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 23 RESEARCH ANTIBODIES AND REAGENTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Increasing research activity and funding for R&D 58
5.2.1.2 Growing industry-academia collaboration 58
TABLE 1 KEY MARKET DRIVERS: IMPACT ANALYSIS 59
5.2.2 RESTRAINTS 59
5.2.2.1 Quality concerns and a lack of reproducible results 59
TABLE 2 KEY MARKET RESTRAINTS: IMPACT ANALYSIS 59
?
5.2.3 OPPORTUNITIES 60
5.2.3.1 Emerging markets 60
5.2.3.2 Personalized medicine and protein therapeutics 60
5.2.3.3 Growth in stem cell and neurobiology research 61
5.2.3.4 Increasing focus on biomarker discovery 61
5.2.3.5 Rising interest in outsourcing 62
TABLE 3 KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS 62
5.2.4 CHALLENGES 62
5.2.4.1 Cost and time-intensive antibody development processes 62
5.2.4.2 Pricing pressure faced by prominent market players 63
TABLE 4 KEY MARKET CHALLENGES: IMPACT ANALYSIS 63
5.3 INDUSTRY TRENDS 63
5.3.1 INCREASING RESEARCH ON THERAPEUTIC ANTIBODIES 64
5.3.2 RECOMBINANT ANTIBODIES SUPPORTING THE SMOOTH TRANSITION FROM IN VITRO TO IN VIVO 64
5.3.3 GROWING CONSOLIDATION OF THE LIFE SCIENCES MARKET FOR ANTIBODIES AND REAGENTS 65
TABLE 5 MAJOR ACQUISITIONS IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET 65
5.4 STAKEHOLDER ANALYSIS 65
FIGURE 24 RESEARCH ANTIBODIES AND REAGENTS MARKETS: STAKEHOLDER ANALYSIS (2021) 67
5.5 STRATEGIC BENCHMARKING 67
TABLE 6 PRODUCT PORTFOLIO ANALYSIS 68
5.6 IMPACT OF COVID-19 ON THE RESEARCH ANTIBODIES AND REAGENTS MARKET 68
5.7 SUPPLY CHAIN ANALYSIS 69
FIGURE 25 RESEARCH ANTIBODIES AND REAGENTS MARKET: SUPPLY CHAIN ANALYSIS 70
5.8 TECHNOLOGY ANALYSIS 70
5.9 REGULATORY ANALYSIS 72
5.10 PORTER'S FIVE FORCES 72
TABLE 7 RESEARCH ANTIBODIES AND REAGENTS MARKET: PORTER'S FIVE FORCES ANALYSIS 72
5.10.1 THREAT OF NEW ENTRANTS 73
5.10.2 THREAT OF SUBSTITUTES 73
5.10.3 BARGAINING POWER OF SUPPLIERS 73
5.10.4 BARGAINING POWER OF BUYERS 73
5.10.5 DEGREE OF COMPETITION 73
5.11 PRICING ANALYSIS 74
TABLE 8 SELLING PRICE OF HPAPI PRODUCTS BY TOP PLAYERS 74
?
6 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT 75
6.1 INTRODUCTION 76
TABLE 9 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 76
6.2 REAGENTS 76
TABLE 10 REAGENTS, BY TYPE 77
TABLE 11 RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 78
TABLE 12 RESEARCH REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 79
6.2.1 MEDIA & SERA 79
6.2.1.1 Media & sera hold the largest share of the reagents market 79
TABLE 13 RESEARCH REAGENTS MARKET FOR MEDIA & SERA, BY COUNTRY, 2020-2027 (USD MILLION) 80
6.2.2 STAINS & DYES 80
6.2.2.1 The growth of the life sciences industry is driving the demand and use of stains & dyes 80
TABLE 14 RESEARCH REAGENTS MARKET FOR STAINS & DYES, BY COUNTRY, 2020-2027 (USD MILLION) 81
6.2.3 FIXATIVES 82
6.2.3.1 Fixative agents are needed to preserve the morphology and antigenicity of target molecules 82
TABLE 15 RESEARCH REAGENTS MARKET FOR FIXATIVES, BY COUNTRY, 2020-2027 (USD MILLION) 82
6.2.4 BUFFERS 83
6.2.4.1 Wide use in drug development will drive the market for buffers 83
TABLE 16 RESEARCH REAGENTS MARKET FOR BUFFERS, BY COUNTRY, 2020-2027 (USD MILLION) 83
6.2.5 SOLVENTS 84
6.2.5.1 Organic solvents see wide use in pharmaceutical processes and assays like IHC 84
TABLE 17 RESEARCH REAGENTS MARKET FOR SOLVENTS, BY COUNTRY, 2020-2027 (USD MILLION) 84
6.2.6 ENZYMES 85
6.2.6.1 An increase in proteomic and genomic research activity will ensure the demand for enzymes 85
TABLE 18 RESEARCH REAGENTS MARKET FOR ENZYMES, BY COUNTRY, 2020-2027 (USD MILLION) 85
6.2.7 PROBES 86
6.2.7.1 The versatility, sensitivity, and quantitative capabilities of probes have ensured their use in research 86
TABLE 19 RESEARCH REAGENTS MARKET FOR PROBES, BY COUNTRY, 2020-2027 (USD MILLION) 86
6.2.8 OTHER REAGENTS 87
TABLE 20 OTHER RESEARCH REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 87
6.3 ANTIBODIES 88
TABLE 21 RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 89
6.3.1 ANTIBODIES, BY TYPE 89
TABLE 22 ANTIBODIES, BY TYPE 89
TABLE 23 RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 90
6.3.1.1 Primary antibodies 90
6.3.1.1.1 Rising R&D activity and expenditure driving the demand for accurate and reliable antibodies 90
TABLE 24 PRIMARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 91
6.3.1.2 Secondary antibodies 91
6.3.1.2.1 Versatility and low cost of production have ensured stable growth in the market for secondary antibodies 91
TABLE 25 SECONDARY RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 92
6.3.2 ANTIBODIES, BY FORM 92
TABLE 26 ANTIBODIES, BY FORM 93
TABLE 27 RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 93
6.3.2.1 Monoclonal antibodies 94
6.3.2.1.1 Monoclonal antibodies are among the most common tools in biomedical science 94
TABLE 28 MONOCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 94
6.3.2.2 Polyclonal antibodies 95
6.3.2.2.1 Thermo Fisher Scientific and Abcam are major players in the polyclonal antibodies market 95
TABLE 29 POLYCLONAL RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 95
6.3.2.3 Recombinant antibodies 96
6.3.2.3.1 Recombinant antibodies provide a highly specific & sensitive option for cancer treatment 96
TABLE 30 RECOMBINANT RESEARCH ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 96
6.3.3 ANTIBODIES, BY SOURCE 96
TABLE 31 ANTIBODIES, BY SOURCE 97
TABLE 32 RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 98
6.3.3.1 Mice 98
6.3.3.1.1 Mice are the preferred hosts for research-use antibody production 98
TABLE 33 MOUSE ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 99
6.3.3.2 Rabbits 99
6.3.3.2.1 Rabbits are a cost-effective means of antibody production 99
TABLE 34 RABBIT ANTIBODIES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 100
6.3.3.3 Other sources 100
TABLE 35 OTHER ANTIBODY SOURCES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 101
6.3.4 ANTIBODIES, BY RESEARCH AREA 101
TABLE 36 ANTIBODIES, BY RESEARCH AREA 101
TABLE 37 RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 103
6.3.4.1 Oncology 103
6.3.4.1.1 High prevalence of cancer has boosted oncology research 103
TABLE 38 RESEARCH ANTIBODIES MARKET FOR ONCOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 104
6.3.4.2 Infectious diseases 104
6.3.4.2.1 Rising awareness and growing research activity are key drivers of the market 104
TABLE 39 RESEARCH ANTIBODIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2020-2027 (USD MILLION) 105
6.3.4.3 Immunology 105
6.3.4.3.1 Antibodies are used to identify protein and peptides to understand infectious disease immunology better 105
TABLE 40 RESEARCH ANTIBODIES MARKET FOR IMMUNOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 106
6.3.4.4 Neurobiology 106
6.3.4.4.1 Antibody-based approaches are widely used in molecular and cellular neuroscience 106
TABLE 41 RESEARCH ANTIBODIES MARKET FOR NEUROBIOLOGY, BY COUNTRY, 2020-2027 (USD MILLION) 107
6.3.4.5 Stem cells 107
6.3.4.5.1 Increasing funding and the growing importance of stem cells in transplantation are key market drivers 107
TABLE 42 RESEARCH ANTIBODIES MARKET FOR STEM CELLS, BY COUNTRY, 2020-2027 (USD MILLION) 108
6.3.4.6 Other research areas 109
TABLE 43 RESEARCH ANTIBODIES MARKET FOR OTHER RESEARCH AREAS, BY COUNTRY, 2020-2027 (USD MILLION) 110
7 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY 111
7.1 INTRODUCTION 112
TABLE 44 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 112
7.2 WESTERN BLOTTING 112
7.2.1 HIGH ACCURACY, EASE OF INTERPRETATION, AND OTHER ADVANTAGES HAVE PROPELLED THE USE OF WESTERN BLOTTING 112
TABLE 45 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR WESTERN BLOTTING, BY COUNTRY, 2020-2027 (USD MILLION) 113
7.3 FLOW CYTOMETRY 114
7.3.1 FLOW CYTOMETRY IS THE FASTEST-GROWING TECHNOLOGY SEGMENT OF THE MARKET 114
TABLE 46 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020-2027 (USD MILLION) 115
7.4 ENZYME-LINKED IMMUNOSORBENT ASSAY 115
7.4.1 ELISA HAS THE POTENTIAL TO SUPERSEDE THE CURRENT GOLD STANDARD FOR COVID-19 TESTING 115
TABLE 47 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ELISA, BY COUNTRY, 2020-2027 (USD MILLION) 116
7.5 IMMUNOHISTOCHEMISTRY 117
7.5.1 COMPLEXITIES OF IHC POSE CHALLENGES TO MARKET GROWTH 117
TABLE 48 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2020-2027 (USD MILLION) 118
7.6 IMMUNOFLUORESCENCE 118
7.6.1 IMMUNOFLUORESCENCE HELPS DETERMINE SPECIFIC GENE EXPRESSIONS 118
TABLE 49 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOFLUORESCENCE, BY COUNTRY, 2020-2027 (USD MILLION) 119
7.7 IMMUNOPRECIPITATION 120
7.7.1 RESULTS OBTAINED BY IP CAN BE ANALYZED THROUGH OTHER TECHNOLOGIES 120
TABLE 50 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR IMMUNOPRECIPITATION, BY COUNTRY, 2020-2027 (USD MILLION) 121
7.8 OTHER TECHNOLOGIES 121
TABLE 51 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020-2027 (USD MILLION) 122
8 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION 123
8.1 INTRODUCTION 124
TABLE 52 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 124
8.2 PROTEOMICS 124
8.2.1 PROTEOMICS HOLDS THE LARGEST SHARE OF THE MARKET, BY APPLICATION 124
TABLE 53 TECHNOLOGICAL APPLICATIONS OF ANTIBODIES IN PROTEOMICS 125
TABLE 54 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PROTEOMICS, BY COUNTRY, 2020-2027 (USD MILLION) 126
8.3 DRUG DEVELOPMENT 126
8.3.1 THE DRUG DEVELOPMENT APPLICATIONS SEGMENT IS EXPECTED TO GROW AT THE HIGHEST RATE 126
FIGURE 26 APPLICATION OF ANTIBODIES IN THE DRUG DEVELOPMENT PROCESS 127
TABLE 55 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR DRUG DEVELOPMENT, BY COUNTRY, 2020-2027 (USD MILLION) 128
8.4 GENOMICS 128
8.4.1 GENOMICS IS AN EMERGING AREA OF RESEARCH APPLICATIONS EXPECTED TO SEE GROWTH IN THE COMING YEARS 128
TABLE 56 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR GENOMICS, BY COUNTRY, 2020-2027 (USD MILLION) 129
9 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER 130
9.1 INTRODUCTION 131
TABLE 57 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 131
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 131
9.2.1 PHARMA & BIOTECH COMPANIES DOMINATE THE END-USER MARKET 131
TABLE 58 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020-2027 (USD MILLION) 132
9.3 ACADEMIC & RESEARCH INSTITUTIONS 132
9.3.1 GROWING GOVERNMENT INVESTMENTS TO PROPEL THE MARKET 132
TABLE 59 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2020-2027 (USD MILLION) 133
9.4 CONTRACT RESEARCH ORGANIZATIONS 134
9.4.1 GROWING CONTRACT RESEARCH ON MONOCLONAL ANTIBODIES AND DRUG CONJUGATES AIDS MARKET GROWTH 134
TABLE 60 RESEARCH ANTIBODIES AND REAGENTS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020-2027 (USD MILLION) 134
10 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION 135
10.1 INTRODUCTION 136
FIGURE 27 RESEARCH ANTIBODIES AND REAGENTS MARKET: GEOGRAPHIC SNAPSHOT (2021) 136
TABLE 61 RESEARCH ANTIBODIES AND REAGENTS MARKET, BY REGION, 2020-2027 (USD MILLION) 137
10.2 NORTH AMERICA 137
FIGURE 28 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT 138
TABLE 62 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 138
TABLE 63 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 139
TABLE 64 NORTH AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 139
TABLE 65 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 139
TABLE 66 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 140
TABLE 67 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 140
TABLE 68 NORTH AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 140
TABLE 69 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 141
TABLE 70 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 141
TABLE 71 NORTH AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 141
10.2.1 US 142
10.2.1.1 The US dominates the North American market in terms of market share 142
TABLE 72 US NIH BUDGET FOR VARIOUS DISCIPLINES, FY 2019 VS. FY 2020 (USD BILLION) 142
TABLE 73 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 143
TABLE 74 US: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 143
TABLE 75 US: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 143
TABLE 76 US: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 144
TABLE 77 US: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 144
TABLE 78 US: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 144
TABLE 79 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 145
TABLE 80 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 145
TABLE 81 US: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 145
10.2.2 CANADA 146
10.2.2.1 Rising cancer incidence and a favorable funding scenario will push market growth in Canada 146
TABLE 82 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 147
TABLE 83 CANADA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 147
TABLE 84 CANADA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 147
TABLE 85 CANADA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 148
TABLE 86 CANADA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 148
TABLE 87 CANADA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 148
TABLE 88 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 149
TABLE 89 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 149
TABLE 90 CANADA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 149
10.3 EUROPE 150
TABLE 91 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 150
TABLE 92 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 150
TABLE 93 EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 151
TABLE 94 EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 151
TABLE 95 EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 151
TABLE 96 EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 152
TABLE 97 EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 152
TABLE 98 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 152
TABLE 99 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 153
TABLE 100 EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 153
10.3.1 GERMANY 153
10.3.1.1 Germany holds the largest share of the market in Europe 153
TABLE 101 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 154
TABLE 102 GERMANY: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 154
TABLE 103 GERMANY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 154
TABLE 104 GERMANY: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 155
TABLE 105 GERMANY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 155
TABLE 106 GERMANY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 155
TABLE 107 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 156
TABLE 108 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 156
TABLE 109 GERMANY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 156
10.3.2 UK 157
10.3.2.1 The market in the UK is characterized by expansions by leading players and growing R&D investments 157
TABLE 110 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 157
TABLE 111 UK: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 158
TABLE 112 UK: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 158
TABLE 113 UK: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 158
TABLE 114 UK: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 159
TABLE 115 UK: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 159
TABLE 116 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 159
TABLE 117 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 160
TABLE 118 UK: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 160
?
10.3.3 FRANCE 160
10.3.3.1 Rising infrastructural development and research activity support market growth in France 160
TABLE 119 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 161
TABLE 120 FRANCE: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 121 FRANCE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 122 FRANCE: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 162
TABLE 123 FRANCE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 162
TABLE 124 FRANCE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 162
TABLE 125 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 163
TABLE 126 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 163
TABLE 127 FRANCE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 163
10.3.4 ITALY 164
10.3.4.1 Increasing R&D in life sciences and favorable funding are key drivers of the Italian market 164
TABLE 128 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 164
TABLE 129 ITALY: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 165
TABLE 130 ITALY: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 165
TABLE 131 ITALY: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 165
TABLE 132 ITALY: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 166
TABLE 133 ITALY: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 166
TABLE 134 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 166
TABLE 135 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 167
TABLE 136 ITALY: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 167
10.3.5 SPAIN 167
10.3.5.1 A favorable scenario for research initiatives drives the market in Spain 167
TABLE 137 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 168
TABLE 138 SPAIN: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 139 SPAIN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 168
TABLE 140 SPAIN: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 169
TABLE 141 SPAIN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 169
TABLE 142 SPAIN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 169
TABLE 143 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 170
TABLE 144 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 170
TABLE 145 SPAIN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 170
10.3.6 REST OF EUROPE 171
TABLE 146 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 171
TABLE 147 REST OF EUROPE: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 148 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 149 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 172
TABLE 150 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 173
TABLE 151 REST OF EUROPE: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 173
TABLE 152 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 173
TABLE 153 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 174
TABLE 154 REST OF EUROPE: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 174
10.4 ASIA PACIFIC 174
FIGURE 29 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET SNAPSHOT 175
TABLE 155 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 176
TABLE 156 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 176
TABLE 157 ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 176
TABLE 158 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 177
TABLE 159 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 177
TABLE 160 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 177
TABLE 161 ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 178
TABLE 162 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 178
TABLE 163 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 178
TABLE 164 ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 179
10.4.1 JAPAN 179
10.4.1.1 Japan dominates the Asia Pacific market 179
TABLE 165 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 180
TABLE 166 JAPAN: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 180
TABLE 167 JAPAN: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 180
TABLE 168 JAPAN: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 181
TABLE 169 JAPAN: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 181
TABLE 170 JAPAN: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 181
TABLE 171 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 182
TABLE 172 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 182
TABLE 173 JAPAN: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 182
10.4.2 CHINA 183
10.4.2.1 China is the fastest-growing segment of the overall market 183
TABLE 174 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 184
TABLE 175 CHINA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 184
TABLE 176 CHINA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 184
TABLE 177 CHINA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 185
TABLE 178 CHINA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 185
TABLE 179 CHINA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 185
TABLE 180 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 186
TABLE 181 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 186
TABLE 182 CHINA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 186
10.4.3 INDIA 187
10.4.3.1 Strong economic growth and rising demand for pharmaceuticals are key market drivers in India 187
TABLE 183 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 187
TABLE 184 INDIA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 188
TABLE 185 INDIA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 188
TABLE 186 INDIA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 188
TABLE 187 INDIA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 189
TABLE 188 INDIA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 189
TABLE 189 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 189
TABLE 190 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 190
TABLE 191 INDIA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 190
10.4.4 REST OF ASIA PACIFIC 190
TABLE 192 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 191
TABLE 193 REST OF ASIA PACIFIC: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 194 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 192
TABLE 195 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 192
TABLE 196 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 192
TABLE 197 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 193
TABLE 198 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 193
TABLE 199 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 193
TABLE 200 REST OF ASIA PACIFIC: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 194
10.5 LATIN AMERICA 194
10.5.1 BRAZIL AND MEXICO TO GROW AT HIGH RATES IN THE LATAM MARKET 194
TABLE 201 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 195
TABLE 202 LATIN AMERICA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 203 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 204 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 196
TABLE 205 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 196
TABLE 206 LATIN AMERICA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 196
TABLE 207 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 197
TABLE 208 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 197
TABLE 209 LATIN AMERICA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 197
10.6 MIDDLE EAST AND AFRICA 198
10.6.1 MEA HOLDS THE SMALLEST SHARE OF THE MARKET BUT IS EXPECTED TO PROVIDE STRONG GROWTH OPPORTUNITIES 198
TABLE 210 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY PRODUCT, 2020-2027 (USD MILLION) 198
TABLE 211 MEA: RESEARCH REAGENTS MARKET, BY TYPE, 2020-2027 (USD MILLION) 199
TABLE 212 MEA: RESEARCH ANTIBODIES MARKET, BY TYPE, 2020-2027 (USD MILLION) 199
TABLE 213 MEA: RESEARCH ANTIBODIES MARKET, BY FORM, 2020-2027 (USD MILLION) 199
TABLE 214 MEA: RESEARCH ANTIBODIES MARKET, BY SOURCE, 2020-2027 (USD MILLION) 200
TABLE 215 MEA: RESEARCH ANTIBODIES MARKET, BY RESEARCH AREA, 2020-2027 (USD MILLION) 200
TABLE 216 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION) 200
TABLE 217 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 201
TABLE 218 MEA: RESEARCH ANTIBODIES AND REAGENTS MARKET, BY END USER, 2020-2027 (USD MILLION) 201
11 COMPETITIVE LANDSCAPE 202
11.1 OVERVIEW 202
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 203
FIGURE 30 KEY DEVELOPMENTS IN RESEARCH ANTIBODIES AND REAGENTS MARKET 203
11.3 RESEARCH ANTIBODIES MARKET SHARE ANALYSIS 204
FIGURE 31 GLOBAL RESEARCH ANTIBODIES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 204
11.4 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 206
FIGURE 32 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN THE RESEARCH ANTIBODIES AND REAGENTS MARKET, 2019-2021 206
11.5 COMPANY EVALUATION QUADRANT 206
11.5.1 STARS 206
11.5.2 EMERGING LEADERS 206
11.5.3 PERVASIVE PLAYERS 207
11.5.4 PARTICIPANTS 207
FIGURE 33 RESEARCH ANTIBODIES AND REAGENTS MARKET: COMPANY EVALUATION QUADRANT, 2021 207
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 208
11.6.1 PROGRESSIVE COMPANIES 208
11.6.2 STARTING BLOCKS 208
11.6.3 RESPONSIVE COMPANIES 208
11.6.4 DYNAMIC COMPANIES 208
FIGURE 34 RESEARCH ANTIBODIES AND REAGENTS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2021 209
11.7 COMPANY FOOTPRINT ANALYSIS 210
11.7.1 COMPANY PRODUCT FOOTPRINT 210
TABLE 219 COMPANY PRODUCT FOOTPRINT: RESEARCH ANTIBODIES AND REAGENTS MARKET (2021) 210
11.7.2 COMPANY REGIONAL FOOTPRINT 211
TABLE 220 COMPANY REGIONAL FOOTPRINT: RESEARCH ANTIBODIES AND REAGENTS MARKET (2021) 211
11.8 COMPETITIVE SITUATION AND TRENDS 212
TABLE 221 PRODUCT LAUNCHES 212
TABLE 222 DEALS 212
TABLE 223 OTHER DEVELOPMENTS 213
12 COMPANY PROFILES 214
(Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1 MAJOR PLAYERS 214
12.1.1 ABCAM PLC. 214
TABLE 224 ABCAM PLC.: BUSINESS OVERVIEW 214
FIGURE 35 ABCAM PLC: COMPANY SNAPSHOT (2021) 215
12.1.2 CELL SIGNALING TECHNOLOGY, INC. 219
TABLE 225 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW 219
12.1.3 THERMO FISHER SCIENTIFIC, INC. 222
TABLE 226 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 222
FIGURE 36 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 223
12.1.4 MERCK KGAA 228
TABLE 227 MERCK KGAA: BUSINESS OVERVIEW 228
FIGURE 37 MERCK KGAA: COMPANY SNAPSHOT (2021) 229
12.1.5 BD 233
TABLE 228 BD: BUSINESS OVERVIEW 233
FIGURE 38 BD: COMPANY SNAPSHOT (2021) 234
12.1.6 BIO-RAD LABORATORIES, INC. 237
TABLE 229 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 237
FIGURE 39 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 238
12.1.7 F. HOFFMANN-LA ROCHE 240
TABLE 230 F. HOFFMANN-LA ROCHE: BUSINESS OVERVIEW 240
FIGURE 40 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2021) 241
12.1.8 AGILENT TECHNOLOGIES, INC. 244
TABLE 231 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 244
FIGURE 41 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021) 245
12.1.9 DANAHER CORPORATION 248
TABLE 232 DANAHER CORPORATION: BUSINESS OVERVIEW 248
FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 249
12.1.10 LONZA 251
TABLE 233 LONZA.: BUSINESS OVERVIEW 251
FIGURE 43 LONZA: COMPANY SNAPSHOT (2021) 252
12.1.11 GENSCRIPT 255
TABLE 234 GENSCRIPT: BUSINESS OVERVIEW 255
FIGURE 44 GENSCRIPT: COMPANY SNAPSHOT (2021) 256
12.1.12 PERKINELMER, INC. 258
TABLE 235 PERKINELMER, INC.: BUSINESS OVERVIEW 258
FIGURE 45 PERKINELMER, INC.: COMPANY SNAPSHOT (2021) 259
12.1.13 BIOLEGEND 262
TABLE 236 BIOLEGEND: BUSINESS OVERVIEW 262
12.1.14 ILLUMINA, INC. 264
TABLE 237 ILLUMINA, INC.: BUSINESS OVERVIEW 264
FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2021) 265
TABLE 238 PRODUCT LAUNCHES 267
12.2 OTHER COMPANIES 269
12.2.1 IMMUNOPRECISE ANTIBODIES LTD 269
TABLE 239 IMMUNOPRECISE ANTIBODIES LTD: COMPANY OVERVIEW 269
12.2.2 FUJIREBIO DIAGNOSTICS AB 270
TABLE 240 FUJIREBIO DIAGNOSTICS AB: COMPANY OVERVIEW 270
12.2.3 ANALYTIK JENA AG 271
TABLE 241 ANALYTIK JENA AG: COMPANY OVERVIEW 271
12.2.4 OMEGA BIO-TEK 272
TABLE 242 OMEGA BIO-TEK: COMPANY OVERVIEW 272
12.2.5 DOVETAIL GENOMICS 273
TABLE 243 DOVETAIL GENOMICS: COMPANY OVERVIEW 273
12.2.6 ATLAS ANTIBODIES 274
TABLE 244 ATLAS ANTIBODIES: COMPANY OVERVIEW 274
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 275
13.1 INSIGHTS OF INDUSTRY EXPERTS 275
13.2 DISCUSSION GUIDE 276
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 282
13.4 AVAILABLE CUSTOMIZATIONS 284
13.5 RELATED REPORTS 284
13.6 AUTHOR DETAILS 285
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security